Navigation Links
Scripps scientist awarded $1.8 million to develop new approaches to lung cancer therapy

JUPITER, FL, January 30, 2014 Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.8 million from the National Cancer Institute of the National Institutes of Health to identify the signaling pathways that underlie lung cancer and to use this information to develop new therapeutic approaches.

Joseph Kissil, a TSRI associate professor, will be principal investigator of the new five-year grant, which extends a study that began in 2006.

Although death rates from lung cancer have fallen in the last 20 years, survival rates are still not good, largely because of a lack of effective treatments for advanced disease.

Kissil's research into non-small cell lung cancer, the most common form of the disease, has shown that a well-known cancer-causing gene implicated in a number of malignancies plays a far more critical role than previously thought. Activating mutations of the K-ras gene are found in more than a third of lung cancers.

"There are clear links between K-ras-induced lung cancer and the receptor known as Notch 1," Kissil said. "A loss of this receptor results in reduced tumor growth. The new grant will let us continue our research into Notch signaling pathways as potentially important therapeutic options for treatment of this disease."


Contact: Eric Sauter
Scripps Research Institute

Page: 1

Related biology news :

1. Scripps Florida scientists offer new insight into neuron changes brought about by aging
2. Scripps leads first global snapshot of key coral reef fishes
3. Scripps Research Institute scientists achieve most detailed picture ever of key part of hepatitis C
4. Scripps oceanography researchers engineer breakthrough for biofuel production
5. NIH awards Scripps Translational Science Institute $29 million grant
6. James Cameron to be publicly honored with Scripps Nierenberg Prize
7. Scripps Research announces research & license agreement with Janssen Pharmaceuticals
8. John Moores gives $2 million to Scripps Research to develop river blindness field test
9. Scripps Research and Takeda Pharmaceuticals announce expanded research collaboration
10. Vibrant mix of marine life found at extreme ocean depths, Scripps analysis reveals
11. Scripps Florida scientist awarded prestigious Javits Neuroscience Investigator Award
Post Your Comments:
Related Image:
Scripps scientist awarded $1.8 million to develop new approaches to lung cancer therapy
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology: